EAG Acquires Chemir

Evans Analytical Group, Inc. (EAG) has acquired Chemir Analytical Services and its affiliates CAS-MI Laboratories and Cyanta Analytical Services. Chemir and CAS-MI will continue to operate under their current names, and Cyanta will be renamed EAG Life Sciences. All three labs will continue operations at their current facilities. Financial terms were not disclosed.

Chemir, based in St. Louis, MO, expands EAG’s service offering for medical device and pharmaceutical companies that require FDA testing beyond materials characterization and clients seeking to develop coating technologies beyond surface analysis investigations. Chemir also gives EAG’s clients greater access to analytical capabilities to determine the source of product failures or help defend a patent infringement case.

Cyanta Analytical Services, also of St. Louis, MO, specializes in cGMP and GLP analytical services such as stability programs, extractables and leachables, bioanalysis and custom synthesis to support pharmaceutical and medical device development. CAS-MI Laboratories of Ypsilanti, MI, provides analytical services for the polymer, paints, coatings, adhesives and sealants industries.

Harry Davoody, chief executive officer of EAG said, “With this acquisition we are excited that EAG can deliver our elite services to customers across a broader range of analytical, test and development offerings. The combination of our companies and integrated scope of services means EAG is a stronger partner for our clients, enabling them to more effectively achieve their time to market or solutions goals.”

David W. Riggs, president of Chemir, said, “Chemir is pleased to become part of an organization as solid as EAG. Over the past year and a half we have experienced our share of hurdles and with EAG as our new owner we have the financial resources and stability our clients deserve. We also feel Chemir’s long-term growth will benefit tremendously from EAG’s global reach and experience with international clients.”